Several preoperative models for predicting MVI have been proposed, incorporating biological markers (e.g., serum alpha-fetoprotein [AFP], neutrophil-to-lymphocyte ratio [NLR]) and morphological characteristics (e.g., tumor size and number, tumor burden score [TBS]) [14,15,16]. The gene discussed is AFP; the disease is neoplasm.